Depressive Disorders - New Zealand

Revenue in the Depressive Disorders market is projected to reach US$8.33m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.07%, resulting in a market volume of US$9.22m by 2029.
In global comparison, most revenue will be generated United States (US$6.26bn in 2024).
In relation to total population figures, per person revenues of US$29.56 are generated in 2024.

Depressive disorders are a common type of mental illness. Symptoms include depressive moods such as feeling sad, low concentration, low self-worth, loss of interest in activities, and, in some cases, thoughts of suicide. Common treatments for depressive disorders include psychological treatments such as psychotherapy, behavioral therapy, and antidepressant medication.

The Depressive Disorders market in the Mental Health market represents the market for antidepressant drug sales. Different types of antidepressants are usually prescribed for the treatment of mild to serious cases of depression, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitor (SNRIs), serotonin modulators, as well as tricyclic and tetracyclic antidepressants.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Novartis AG, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Patheon Inc, and Sandoz Inc.

Antidepressant drugs
Selective serotonin reuptake inhibitors (SSRIs)
Serotonin norepinephrine reuptake inhibitor (SNRIs)
Serotonin modulators
Tricyclic and tetracyclic antidepressants

Psychotherapy
Mood stabilizers
Anti-anxiety and stimulant medications
Behavioral therapy

The Depressive Disorders market in New Zealand is experiencing steady growth due to increasing customer preferences for mental health treatment options, as well as several key trends in the market.

Customer preferences: Customers in New Zealand are increasingly seeking out treatment options for depressive disorders, leading to a growing demand for products and services in the market. This can be attributed to a number of factors, including a greater awareness and understanding of mental health issues, as well as a reduced stigma surrounding seeking help for mental health conditions. As a result, individuals are more likely to seek treatment for depressive disorders, leading to a higher demand for medications, therapy services, and other treatment options.

Trends in the market: One key trend in the Depressive Disorders market in New Zealand is the increasing use of digital health solutions. With the rise of telehealth and online therapy services, individuals are now able to access mental health treatment from the comfort of their own homes. This has made treatment more accessible and convenient, particularly for individuals in rural areas or those with limited mobility. Additionally, the use of digital health solutions has also allowed for greater personalization and customization of treatment plans, leading to improved outcomes for patients.Another trend in the market is the growing focus on holistic approaches to mental health treatment. Rather than relying solely on medications, individuals are increasingly seeking out alternative therapies such as mindfulness, meditation, and yoga. These approaches are often seen as more natural and have fewer side effects, making them an attractive option for many individuals. Additionally, the focus on holistic approaches aligns with the overall trend towards wellness and self-care, which is gaining popularity globally.

Local special circumstances: New Zealand has a unique cultural context that may influence the development of the Depressive Disorders market. The country has a strong focus on mental health and well-being, with the government implementing various initiatives to promote mental health awareness and support. This cultural emphasis on mental health likely contributes to the growing demand for treatment options in the market.

Underlying macroeconomic factors: The New Zealand economy has been relatively stable in recent years, which has likely contributed to the growth of the Depressive Disorders market. A stable economy generally leads to increased consumer spending and investment in healthcare, including mental health services. Additionally, the government has also made investments in mental health services, further driving growth in the market.In conclusion, the Depressive Disorders market in New Zealand is experiencing growth due to increasing customer preferences for mental health treatment options, as well as key trends such as the use of digital health solutions and a focus on holistic approaches. The unique cultural context and stable economy of New Zealand also contribute to the development of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.